News
The First Real-world Assessment of BBV152, a COVID-19 Vaccine Developed by Bharat Biotech ... - Latest Tweet by ANI
The latest Tweet by ANI states, 'The first real-world assessment of BBV152, a COVID-19 vaccine developed by Bharat Biotech suggests that two vaccine doses result in 50% effectiveness against symptomatic COVID-19, according to the study published in The Lancet Infectious Diseases journal'
The first real-world assessment of BBV152, a COVID-19 vaccine developed by Bharat Biotech suggests that two vaccine doses result in 50% effectiveness against symptomatic COVID-19, according to the study published in The Lancet Infectious Diseases journal— ANI (@ANI) November 24, 2021
(The above story first appeared on LatestLY on Nov 24, 2021 08:20 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
